PTK6

Chr 20

protein tyrosine kinase 6

Also known as: BRK

NCBI Gene: 5753 ENSG00000101213 UniProt: Q13882

The protein encoded by this gene is a cytoplasmic non-receptor tyrosine kinase that regulates epithelial cell differentiation, maintenance, and signaling pathways including EGFR, STAT3/5, and various RNA-binding proteins. This gene is extremely intolerant to loss-of-function variants in the general population, but no Mendelian pediatric neurogenetic disorders have been established from mutations in PTK6 based on current evidence. The gene's primary known associations are with epithelial biology and cancer rather than inherited neurological conditions.

ResearchSummary from RefSeq, UniProt

The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]

ResearchGenerating clinical summary…

MultiplemechanismLOEUF 1.34

Clinical Summary— PTK6

⚡

Population Constraint (gnomAD)

Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Explore recent and relevant literature in Research Assistant →

Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

gnomAD

Tolerant — LoF & missense variants common in population

LoF Constraint?

1.34LOEUF

pLI 0.000

Z-score 0.33

OE 0.92 (0.65–1.34)

Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?

0.39Z-score

OE missense 0.93 (0.85–1.03)

270 obs / 288.8 exp

Tolerant

Mild missense constraint

Observed / Expected Ratios?

LoF OE?0.92 (0.65–1.34)

0≤0.351.4

Missense OE?0.93 (0.85–1.03)

0≤0.61.4

Synonymous OE?1.08

0≤1.21.6

LoF obs/exp: 20 / 21.7Missense obs/exp: 270 / 288.8Syn Z: -0.76

This gene — mechanism propensity

0.6745th %ile

GOF

0.74top 25%

LOF

0.3164th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.